Phase II single-arm study of a combination of obinutuzumab and venetoclax in early relapsed or refractory diffuse large B-cell lymphoma—final results of the AGMT NHL15B study - Jaeger, Ulrich; Simonitsch-Klupp, Ingrid; Klammer, Patrick; Egle, Alexander; Heibl, Sonja; Neumeister, Peter; Willenbacher, Ella; Erlsbacher, Florian; Larcher-Senn, Julian; Staber, Philipp B.; Porpaczy, Edit; Skrabs, Cathrin; et al. (Frontiers in Hematology, 2024)